Joint Industry Statement on Internet Sales and Access to Safe Medicines

Infographic 31 May 2023

Navigating the ECOWAS Joint Assessment Procedure

The ECOWAS Joint Assessment Procedure is a collaborative initiative among 15 National Regulatory Agencies in West Africa that ensures harmonized and streamlined market authorization of medical products across the region. This infographic provides an overview of key steps and timelines applicants need to bear in mind during the Joint Assessment Procedure.

Key considerations on the scope, utility and processes around updating the WHO Essential Medicines List

The WHO Essential Medicines List (EML) is an important tool in global health and supports the achievement of the UN Sustainable Development Goals. IFPMA has published perspectives from the R&D-based industry on the utility and scope of the EML. This position paper represents IFPMA's perspective as of April 2023, ahead of the publication of the revised version of the EML.

Registration of multiple manufacturing sites in one product license

In a joint position paper, EFPIA, IFPMA and Vaccines Europe urge all countries to adopt a ‘multiple-site-to-one-license’ approach for registrations, in line with WHO and other guidelines. This will result in a reduction of duplicate work for all stakeholders, help to build agility and speed in supply chain management and improve patient access to medicines and vaccines.